We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGFY
601
DELISTED
Signify Health, Inc.
SGFY
-5,627,568
Closed -$161M
ONEM
602
DELISTED
1Life Healthcare
ONEM
-8,459,920
Closed -$141M

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.